Jorge Tartaglione Reports Fibromyalgia Affects One Million in Argentina
- Fibromyalgia affects 3% of the global population, translating to nearly one million people in Argentina alone, Jorge Tartaglione reported.
- Patients face significant frustration during the initial diagnostic process because traditional laboratory tests and blood panels return entirely normal results.
- This lack of objective laboratory findings often leads practitioners to deliver dismissive or erroneous evaluations.
Fibromyalgia affects 3% of the global population, translating to nearly one million people in Argentina alone, Jorge Tartaglione reported. The condition remains frequently misunderstood by the medical community, leaving patients to suffer at home without proper clinical management, according to the specialist.
The Diagnostic Process and Misconceptions
Patients face significant frustration during the initial diagnostic process because traditional laboratory tests and blood panels return entirely normal results. They do all the tests, and they’re normal. They do blood lab tests, and they’re normal, and you say, “What could this be?
Tartaglione explained regarding the confusion patients experience when physical tests fail to explain their symptoms.
This lack of objective laboratory findings often leads practitioners to deliver dismissive or erroneous evaluations. Patients frequently hear that their condition is psychological or tied to nervousness and menopause, responses that foster isolation and worsen their clinical state.
Nervous System Alterations and Symptoms
Medical evaluation shows that fibromyalgia extends beyond localized pain, presenting instead as a widespread, cold, cramping, and painful sensation accompanied by extreme fatigue. A frequent symptom is fibrofog, defined by experts as a mental fog that obstructs clear reasoning. The root cause stems from a nervous system alteration that elevates the body’s pain perception threshold.
Current medical protocols no longer classify fibromyalgia strictly as a diagnosis of exclusion. Criteria now demand persistent pain lasting at least three months, fatigue, and standardized evaluation indices, moving past the misconception that the illness is imaginary.
Multidisciplinary Treatment Frameworks
Successful management requires a collaborative medical structure involving multiple specialists rather than a single approach. The approach is multidisciplinary. Many people must be involved in this treatment.
Tartaglione stated.
The therapeutic plan rests on four core pillars designed to address both physical and emotional symptoms. Physical strength training serves as the central axis, supported by psychotherapy for emotional management, targeted pharmacotherapy, and patient education. Sit down with your doctor, talk to each other, feel understood, and have empathy for the illness.
Tartaglione advised regarding patient communication.